The benefits - and challenges - of in-house CAR T-cell therapy Labiotech.eu
The benefits - and challenges - of in-house CAR T-cell therapy Labiotech.eu
Exploring the Potential of Cell Therapy Technologies Market in the ...
Global Stem Cells Group (GSCG) and International Society for Stem ... Digital Journal
Takeda Presents Positive Results from Phase 3 Study of ... Business Wire
Data Presented on Gamida Cell's Omidubicel, GDA-201 at the 2023 ... Business Wire
I Struggled With Panic Attacks Then I Tried Psychedelic Therapy ... mindbodygreen
Affimed (AFMD) Shifts Attention To Risky Combination Therapy Seeking Alpha
The optimization of postoperative radiotherapy in de novo stage IV ... Nature.com
30 Beauty Experts Share Their Favorite Cheap Product On Amazon ... Bustle
SAN DIEGO When biologist Alysson Muotri started tinkering with tiny balls of nerve cells in the lab more than a decade ago, his goal was simply to understand early brain development and neurological disease. He didnt realize he was stumbling into an ethical minefield. His University of California, San Diego, team found that when human stem cells were grown into so-called brain organoids in the lab, these tiny 3D structures produced regular waves of electrical activity that resembled what researchers see in a full-size human brain when they place electrodes along a persons scalp. These brain models were a useful tool to better understand conditions such as autism and schizophrenia, which could help researchers develop and test new treatments.
Recent Comments